By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Regeneron Pharmaceuticals, Inc. 

777 Old Saw Mill River Road

Tarrytown  New York  10591  U.S.A.
Phone: 914-847-7000 Fax: n/a


SEARCH JOBS



Known for its scientific and operational excellence, Regeneron is a leading science-based biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron markets medicines for eye diseases, colorectal cancer, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, oncology, rheumatoid arthritis, allergic asthma, and atopic dermatitis.

Visit our website – www.regeneron.com
Check out our openings – http://careers.regeneron.com


Key Statistics


Email:
Ownership: Public

Web Site: Regeneron
Employees: 2300+
Symbol: REGN
 



Industry
Biotechnology


Collaborations

Sanofi US 

Bayer 

Geisinger Health System  Collaboration with Regeneron Genetics Center LLC, wholly-owned subsidiary of Regeneron.

Avalanche Biotech 





Company News
Regeneron (REGN) Rapid Response Platform For Emerging Infectious Diseases Described In Proceedings Of The National Academy of Sciences Publication 6/30/2015 7:48:37 AM
Regeneron (REGN) Release: EYLEA (aflibercept) Injection Receives Approval In Japan For The Treatment Of Retinal Vein Occlusion 6/26/2015 6:51:42 AM
Regeneron (REGN) Announces 2015 Winners Of The Regeneron Prize For Creative Innovation 6/25/2015 11:45:15 AM
Analysts Question Avalanche Biotech (AAVL) Clinical Data, Could Jeopardize Regeneron (REGN) Deal 6/16/2015 6:31:28 AM
Why Is Amgen (AMGN) Rising And Regeneron (REGN) Falling? 6/12/2015 6:51:47 AM
FDA Advisory Committee Recommends Approval Of Regeneron (REGN) And Regeneron (REGN)'s Praluent (Alirocumab) Injection For Patients With Hypercholesterolemia 6/10/2015 7:59:25 AM
FDA Advisors Back Regeneron (REGN), Sanofi (SAN.PA)'s New Heart Drug With Limits 6/10/2015 6:07:23 AM
Regeneron (REGN) Trading Halted While FDA Considers New Drug Developed With Sanofi (SAN.PA) 6/9/2015 7:36:30 AM
FDA Staff Says Regeneron (REGN), Sanofi (SAN.PA) Drug Cuts Cholesterol But Questions Benefits 6/8/2015 6:42:13 AM
Regeneron (REGN) and Sanofi (SAN.PA) Partnership Records Another Hit In Latest String of Successes 5/21/2015 6:30:06 AM
12345678910...
//-->